REV-ERB agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-06-10. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule ligand; not a hormone or peptide |
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| CAS Registry Number | 1379686-30-2 | Unique chemical identifier |
| Common synonyms | SR9009; stenabolic | Stenabolic is informal and not an official name |
| Reported targets | REV-ERBα and REV-ERBβ | Nuclear receptors linked to circadian and metabolic regulation |
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
==== Debate ==== Some question if patent waiver proposals formulated for small molecule drugs can be applied to complex biologics like vaccines. One vaccine production expert argued that "there is an unrecognized gap in understanding ... nearly all of the people who are providing views on the value of removing patent protections have zero experience in vaccine development and manufacturing." Indeed, most of the advocacy in favor of patent waivers has come from the public health community (which has drawn inspiration from the history of raucous HIV/AIDS activism in the 1980s and 1990s), while most members of the vaccinology community (i.e., actual experts on development and production of vaccines) have effectively refused to lend their credibility to such proposals by either remaining silent or refusing to take any position. Small molecule drugs are easy to copy and can be quickly brought to market by generic drug manufacturers who are not required to run their own full-scale clinical trials because they can piggyback on regulatory approvals obtained by original drug manufacturers. In contrast, "there is no such thing as generic vaccines". The manufacturer of each independently developed vaccine (including a purported copy of an existing vaccine) must run its own clinical trials to establish safety and efficacy. Independent copying of an existing first-generation vaccine is so hard that the resulting second-generation vaccine is often a significant improvement over the first-generation technology and is itself patentable.
=== Spray drying === King later turned to spray drying of beverages and other liquids, for which the loss of volatile flavor and aroma substances occurs largely in the spray-nozzle zone, where the droplets to be dried are formed. King and his colleagues examined factors influencing the loss of volatile flavors and aroma and also the factors affecting the development of particle morphology (size, shape, porosity, and thus the bulk density) of the dried product. They interpreted the factors that cause spray-dried particles to be sticky. In later research, King and his colleagues created a device to enable simultaneous measurement of particle morphology and loss of volatile components as the drying of single drops to particles took place. This research was supported by the National Science Foundation. He prepared review articles on retention of volatile flavor and aroma components during spray drying. In later research, King and his colleagues created a device to enable simultaneous measurement of particle morphology and loss of volatile components as the drying of single drops to particles took place.
Certain inks, coatings, and adhesives are formulated with photoinitiators and resins. When exposed to UV light, polymerization occurs, and so the adhesives harden or cure, usually within a few seconds. Applications include glass and plastic bonding, optical fiber coatings, the coating of flooring, UV coating and paper finishes in offset printing, dental fillings, hydrophobic light-activated adhesive, and decorative fingernail "gels". UV sources for UV curing applications include UV lamps, UV LEDs, and excimer flash lamps. Fast processes such as flexo or offset printing require high-intensity light focused via reflectors onto a moving substrate and medium so high-pressure Hg (mercury) or Fe (iron, doped)-based bulbs are used, energized with electric arcs or microwaves. Lower-power fluorescent lamps and LEDs can be used for static applications. Small high-pressure lamps can have light focused and transmitted to the work area via liquid-filled or fiber-optic light guides. The impact of UV on polymers is used for modification of the (roughness and hydrophobicity) of polymer surfaces. For example, a poly(methyl methacrylate) surface can be smoothed by vacuum ultraviolet. UV radiation is useful in preparing low-surface-energy polymers for adhesives. Polymers exposed to UV will oxidize, thus raising the surface energy of the polymer. Once the surface energy of the polymer has been raised, the bond between the adhesive and the polymer is stronger.
=== Sportspeople === Cyclist and Olympic gold medalist Anna Meares said "Unfair, unsafe – I just don't think this is the right way to go about sport." Cyclist Joseph M. Papp, suspended for doping in 2006, referred to a 1988 Weekend Update skit, saying: "I don't think you'd actually see guys tearing their arms off ... A doping free-for-all just invites the most ambitious person to be the most reckless person, and to take the most drugs possible without literally killing themselves." Badminton player Susan Egelstaff stated, "It cannot, and will not work. The danger is massive." Swimmer and Olympic gold medalist Leisel Jones stated that while she would not participate herself due to the risks, she'd be interested in how fast people could get with doping, saying: "If this clears out people who ... are doing illegal things in sport, if that clears them out our clean sport, that would be wonderful." Swimmer and Olympic gold medalist Libby Trickett said it was understandable TEG would attract fascination and interest, and that "I really, really, really hope that it's done under medical supervision because that's the only way I can kind of justify in my head something like this to go ahead." Olympic swimmer Mark Foster expressed similar views, noting also that money has attraction.
Sources: en.wikipedia.org
RNA sequences at lengths of 30 nucleotides, 60 nucleotides, 100 nucleotides, and 140 nucleotides, were capable of catalysis of "the synthesis of three common coenzymes, CoA, NAD, and FAD, from their precursors, 4'-phosphopantetheine, NMN, and FMN, respectively".
Initial letters are used where there is no ambiguity: C cysteine, H histidine, I isoleucine, M methionine, S serine, V valine. No other amino acids in this set begin with each of those letters. Where arbitrary assignment is needed, the structurally simpler amino acids are given precedence: A alanine, G glycine, L leucine, P proline, T threonine. For example, alanine is simpler than arginine or asparagine, the other amino acids starting with "a". F PHenylalanine and R aRginine are assigned by being phonetically suggestive, W tryptophan is assigned based on the double ring being visually suggestive to the bulky letter W, K lysine and Y tyrosine are assigned as alphabetically nearest to their initials L and T (note that U was avoided for its similarity with V, while X was reserved for undetermined or atypical amino acids); for tyrosine the mnemonic tYrosine was also proposed, D aspartate was assigned arbitrarily, with the proposed mnemonic asparDic acid; E glutamate was assigned in alphabetical sequence being larger by merely one methylene –CH2– group, N asparagine was assigned arbitrarily, with the proposed mnemonic asparagiNe; Q glutamine was assigned in alphabetical sequence of those still available (note again that O was avoided due to similarity with D), with the proposed mnemonic Qlutamine.
== Other animals == Bowed tendon is a term for form of tendinitis (inflammation) and tendinosis (degeneration) most commonly seen in the superficial digital flexor tendon in the front leg of horses. Mesenchymal stem cells, derived from a horse's bone marrow or fat, can be used for tendon repair in horses.
Sources: en.wikipedia.org
== Reproduction and development == Eggs are laid in an ootheca which the female carries out the end of her abdomen for varying lengths of time. When ready she either deposits it on the ground, or attaches it to an object. The hardened ootheca helps protect the developing eggs. Optimal temperature range and patterns effect the hatch rate. Research has found that the best hatch rates occur when temperature alternates between 5°C and 30°C (the ootheca were left at the lower temperature for seven days, then left at the higher temperature for the remainder of development), the development time averages 44 days. Less effective temperature combinations may result in longer development times, alternating 10°C and 25°C, averages 61 days. E. sinensis is considered to have a flexible life cycle, as length can vary from 1 to 3 years, depending on latitude the population is from. Females can survive up to 30 months, while males lifespan is much shorter. The variable lifespans correlates to varying number of instars, 7 to 9, or 9 to 11. Males generally develop faster than females. The species takes longer to develop at lower temperatures.
=== Relations with Tibet === In the fall of 1933, the 13th Dalai Lama sent an ultimatum to Liu Wenhui stating that Tibet would launch another attack if the 24th Army did not retreat further east. The ultimatum was not followed up because of the Lama's death on 17 December. In the wake of the ensuing political instability within the region, Liu cabled Nanjing for an expeditionary force to restore Chinese control over the entirety of Tibet. However, Dai Jitao and other close advisors to Chiang Kai-shek chose a more conciliatory policy and urged restraint on 23 December, which Liu Wenhui again ignored. Here, historian James Leibold speculates that Liu would probably have seized Lhasa had it not been for his untimely defeat at the hands of his nephew. In 1934, the new Tibetan government of Jamphel Yeshe Gyaltsen was ready to pursue peace with the central government, as the war with Liu had drained the monasteries' resources and driven up the price of Chinese tea. Chiang dispatched General Huang Musong on a diplomatic mission to Lhasa, with the aim of getting Tibet to accept Chinese sovereignty in exchange for broad autonomy. This mission, although accepted by the Kashag, was foiled when Liu Wenhui met with Huang in Chengdu and urged a hard line on the border issue. This was anathema to the Tibetans who wanted a demilitarized buffer zone in Xikang to protect from Liu Wenhui's army.
== Biography == Edlich was admitted to Lafayette College at age 15 after finishing his sophomore year at Stuyvesant High School in New York City. Three years later, he enrolled as an early admission student at New York University School of Medicine. After graduating in 1970, he began a surgical residency at the University of Minnesota Health Sciences Center and received a Doctorate of Philosophy in Surgery.
== Expression and regulation == The liver has the highest iNAMPT activity of any organ, about 10-20 times greater activity than kidney, spleen, heart, muscle, brain or lung. iNAMPT is downregulated by an increase of miR-34a in obesity via a 3'UTR functional binding site of iNAMPT mRNA resulting in a reduction of NAD(+) and decreased SIRT1 activity. Endurance-trained athletes have twice the expression of iNAMPT in skeletal muscle compared with sedentary type 2 diabetic persons. In a six-week study comparing legs trained by endurance exercise with untrained legs, iNAMPT was increased in the endurance-trained legs. A study of 21 young (under 36) and 22 old (over 54) adults subject to 12 weeks of aerobic and resistance exercise showed aerobic exercise to increase skeletal muscle iNAMPT 12% and 28% in young and old (respectively) and resistance exercise to increase skeletal muscle iNAMPT 25% and 30% in young and old (respectively). Aging, obesity, and chronic inflammation all reduce iNAMPT (and consequently NAD+) in multiple tissues, and NAMPT activity was shown to promote a proinflammatory transcriptional reprogramming of immune cells (e.g. macrophages) and brain-resident astrocytes.
Sources: en.wikipedia.org
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.
No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.
Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.